BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26541525)

  • 1. Lung cancer survival in Norway, 1997-2011: from nihilism to optimism.
    Nilssen Y; Strand TE; Fjellbirkeland L; Bartnes K; Møller B
    Eur Respir J; 2016 Jan; 47(1):275-87. PubMed ID: 26541525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years.
    van der Drift MA; Karim-Kos HE; Siesling S; Groen HJ; Wouters MW; Coebergh JW; de Vries E; Janssen-Heijnen ML
    J Thorac Oncol; 2012 Feb; 7(2):291-8. PubMed ID: 22157366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Lung Cancer Mortality in a Referral Center.
    Jamaati H; Baghaei P; Sharifianfard M; Emami H; Najmi K; Seifi S; Salimi B; Pourabdollah M; Kiani A; Hashemian M; Khosravi A
    Asian Pac J Cancer Prev; 2016; 17(6):2877-81. PubMed ID: 27356706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Govindan R
    J Thorac Oncol; 2009 Dec; 4(12):1524-9. PubMed ID: 19752759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrence and survival after surgical treatment of lung cancer].
    Hjelde H; Sundstrøm S; Ødegård A; Hatlinghus S; Abusland AB; Haaverstad R
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):25-8. PubMed ID: 20094119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression is not a marker of poor survival in lung cancer.
    Turk HM; Camci C; Sevinc A; Bukyukberber S; Sari I; Adli M
    Asian Pac J Cancer Prev; 2012; 13(1):315-8. PubMed ID: 22502692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with lung cancer in the city of Manaus, Brazil.
    Westphal FL; Lima LC; Andrade EO; Lima Netto JC; Silva AS; Carvalho BC
    J Bras Pneumol; 2009 Feb; 35(2):157-63. PubMed ID: 19287919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.
    Koumarianou A; Fountzilas G; Kosmidis P; Klouvas G; Samantas E; Kalofonos C; Pentheroudakis G; Economopoulos T; Pectasides D
    J Chemother; 2009 Nov; 21(5):573-83. PubMed ID: 19933050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and lung cancer survival: a population-based study in Norway.
    Brancher S; Støer NC; Weiderpass E; Damhuis RAM; Johannesen TB; Botteri E; Strand TE
    Br J Cancer; 2021 Mar; 124(5):1018-1025. PubMed ID: 33262518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.
    Zhang K; Lai Y; Axelrod R; Campling B; Hyslop T; Civan J; Solomides C; Myers RE; Lu B; Bar Ad V; Li B; Ye Z; Yang H
    Int J Cancer; 2015 Jan; 136(2):382-91. PubMed ID: 24866905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
    Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
    J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
    Svensson G; Ewers SB; Ohlsson O; Olsson H
    Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.